株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

人工血管市場 - 成長、傾向、および予測(2019-2024)

Vascular Graft Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 871390
出版日 ページ情報 英文 114 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
人工血管市場 - 成長、傾向、および予測(2019-2024) Vascular Graft Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年05月01日 ページ情報: 英文 114 Pages
概要

世界の人工血管市場は2019年から2024年の間に5.7%のCAGRで成長すると予測されています。

当レポートでは世界の人工血管市場について調査しており、市場概況および成長要因・阻害要因、製品・用途・原料・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報をまとめています。

目次

第1章 イントロダクション

  • 研究成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概況
  • 市場成長要因
    • 生活習慣病の罹患率の増加
    • スキャフォールド材料と人工血管のデザインの技術的進歩
  • 市場の阻害要因
    • 不利な償還シナリオ
    • 移植不全に伴う高リスク
  • ポーターファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競争

第5章 市場セグメント

  • 製品別
    • 血液透析アクセスグラフト
    • 血管内ステントグラフト
    • 末梢血管移植
    • 冠状動脈バイパス術
  • 用途別
    • 動脈瘤
    • 腎不全
    • 血管閉塞
    • 冠状動脈疾患
    • その他の用途
  • 原料別
    • 合成原料
    • 生物学的原料
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東およびアフリカ
    • 南米

第6章 競争力のある風景

  • 企業プロファイル
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Bard Peripheral Vascular Inc. (BD)
    • Cardinal Health (Cordis)
    • Cook Medical
    • Cryolife
    • Getinge Group
    • LeMaitre Vascular Inc
    • Medtronic PLC
    • テルモ株式会社
    • W.L. Gore & Associates Inc

第7章 市場機会および今後の動向

目次
Product Code: 62301

Market Overview

The global Vascular Graft market is expected to register a CAGR of 5.7% over the forecast period. Key factors contributing to the market growth are rising prevalence of cardiac diseases, increasing prevalence of diabetes, and end-stage renal diseases, coronary artery disease (CAD), hypertension and cardiac aneurysms. Apart from the mentioned factors, genetic and hereditary factors, unhealthy lifestyle, alcohol consumption, tobacco smoking, etc., are expected to increase the demand for vascular grafts over the period. Low reimbursement rate and rising out-of-pocket expenses in an emerging economy can restrain market growth.

Scope of the Report

Vascular grafts are medical devices which are used in vascular bypass procedures to direct the blood flow from one area to another by reconnecting the blood vessels. The report covers revenue generated by the sale of hemodialysis access grafts, endovascular stent grafts, peripheral vascular grafts, and coronary artery bypass grafts.

Key Market Trends

Hemodialysis Access Graft Segment is Expected to Register Robust Growth

The global prevalence of end-stage renal diseases (ESRD) is increasing at a significant rate, as chronic kidney diseases (CKD) may develop over many years leading to ESRD. nearly Two million people worldwide suffer from ESRD, and the number of patients diagnosed with the disease continues to increase at a rate of 5-7% per year.

The aging population is further aggravating the increasing prevalence of ESRD. According to the Ministry of Health of the People's Republic of China's statistics the prevalence of chronic kidney disease among females in the Chinese general population increases from 7.4% among those aged 18-39 years to an estimated 18.0% and 24.2% among those aged 60-69 and 70 years respectively.

Apart from kidney transplant dialysis is the primary management option for patients with ESRD. Vascular access is considered as the lifeline of a patient on hemodialysis for better treatment and safety. For long-term use, majorly, two types of vascular access are designed: arteriovenous (AV) fistula and the AV graft, while the venous catheter is designed for short-term use. AV fistula is a direct connection of an artery to a vein made by a surgeon, whereas in AV graft, a plastic tube is used to connect an artery to a vein.

North America is Expected to Retain Largest Market Share During the Forecast Period

North America dominates the vascular grafts market. North America maintained its dominant share due to the high prevalence rate of diabetes, cardiovascular diseases, and chronic kidney disease. Presence of reimbursement coverage and availability of state-of-the-art healthcare infrastructure are driving the growth of this market in North America. Asia-Pacific is anticipated to show the fastest growth during the forecast period due to increasing incidences of cardiovascular disease & diabetes and improving healthcare infrastructure.

Competitive Landscape

Key players in the market include Abbott Laboratories, B. Braun Melsungen AG, Bard Peripheral Vascular Inc. (BD), Cardinal Health (Cordis), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic plc, Terumo Medical Corporation, and W.L. Gore & Associates Inc among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Lifestyle-related Disorders
    • 4.2.2 Technological Advancements in the Scaffold Material and Design of Vascular Grafts
  • 4.3 Market Restraints
    • 4.3.1 Unfavorable Reimbursement Scenario
    • 4.3.2 High Risk Associated with Graft Failures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Hemodialysis Access Graft
    • 5.1.2 Endovascular Stent Graft
    • 5.1.3 Peripheral Vascular Graft
    • 5.1.4 Coronary Artery By-pass Graft
  • 5.2 By Application
    • 5.2.1 Aneurysms
    • 5.2.2 Kidney Failure
    • 5.2.3 Vascular Occlusion
    • 5.2.4 Coronary Artery Diseases
    • 5.2.5 Other Applications
  • 5.3 By Raw Material
    • 5.3.1 Synthetic Raw Material
    • 5.3.2 Biological Raw Material
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Bard Peripheral Vascular Inc. (BD)
    • 6.1.4 Cardinal Health (Cordis)
    • 6.1.5 Cook Medical
    • 6.1.6 Cryolife
    • 6.1.7 Getinge Group
    • 6.1.8 LeMaitre Vascular Inc
    • 6.1.9 Medtronic PLC
    • 6.1.10 Terumo Medical Corporation
    • 6.1.11 W.L. Gore & Associates Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top